Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade

Diabetic kidney disease is the most frequent cause of end-stage renal disease. This implies failure of current therapeutic approaches based on renin-angiotensin system (RAS) blockade. Recent phase 3 clinical trials of paricalcitol in early diabetic kidney disease and bardoxolone methyl in advanced d...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Med
Main Authors: Perez-Gomez, Maria Vanessa, Sanchez-Niño, Maria Dolores, Sanz, Ana Belen, Martín-Cleary, Catalina, Ruiz-Ortega, Marta, Egido, Jesus, Navarro-González, Juan F., Ortiz, Alberto, Fernandez-Fernandez, Beatriz
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2015
Fag:
Review
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4485003/
https://ncbi.nlm.nih.gov/pubmed/26239562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm4061325
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker